Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Sirolimus is more effective and burdened
with less side effects than conventional treatment with corticosteroids in patients with
active thyroid eye disease.